Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Rekha RaoKapil Bhalla

Abstract

Bortezomib induces unfolded protein response (UPR) and endoplasmic reticulum stress, as well as exhibits clinical activity in patients with relapsed and refractory mantle cell lymphoma (MCL). Here, we determined the molecular basis of the improved in vitro and in vivo activity of the combination of the pan-histone deacetylase inhibitor panobinostat and bortezomib against human, cultured, and primary MCL cells. Immunoblot analyses, reverse transcription-PCR, and immunofluorescent and electron microscopy were used to determine the effects of panobinostat on bortezomib-induced aggresome formation and endoplasmic reticulum stress in MCL cells. Treatment with panobinostat induced heat shock protein 90 acetylation; depleted the levels of heat shock protein 90 client proteins, cyclin-dependent kinase 4, c-RAF, and AKT; and abrogated bortezomib-induced aggresome formation in MCL cells. Panobinostat also induced lethal UPR, associated with induction of CAAT/enhancer binding protein homologous protein (CHOP). Conversely, knockdown of CHOP attenuated panobinostat-induced cell death of MCL cells. Compared with each agent alone, cotreatment with panobinostat increased bortezomib-induced expression of CHOP and NOXA, as well as increased bort...Continue Reading

References

Dec 29, 1998·The Journal of Cell Biology·J A JohnstonR R Kopito
Jul 19, 2001·Nature·A M ReimoldL H Glimcher
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N S AndersenC H Geisler
Feb 4, 2005·The Journal of Clinical Investigation·Kezhong ZhangRandal J Kaufman
Jun 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Teru HideshimaKenneth C Anderson
Jan 7, 2006·Nature Reviews. Cancer·Saverio Minucci, Pier Giuseppe Pelicci
Sep 6, 2006·EMBO Reports·Eva SzegezdiAfshin Samali
Apr 10, 2007·Cancer Cell·Daniel R CarrascoRonald A DePinho
Jun 15, 2007·Nature Reviews. Molecular Cell Biology·David Ron, Peter Walter
Jul 3, 2007·Cell·Hamsa PuthalakathAndreas Strasser
Sep 6, 2007·Genes & Development·Cyril BoyaultSaadi Khochbin
Nov 10, 2007·Science·Jonathan H LinPeter Walter
Jan 17, 2008·Cell Cycle·Patrick MatthiasSaadi Khochbin
Jan 29, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yun DaiSteven Grant
Feb 23, 2008·The Biochemical Journal·Laurence H PearlPaul Workman
Jun 10, 2008·Current Opinion in Hematology·Mitchell R Smith
Sep 17, 2008·Molecular and Cellular Biology·Matthew H Brush, Shirish Shenolikar
Sep 27, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·David J McConkey, Keyi Zhu
Oct 29, 2008·Hematology/oncology Clinics of North America·Christian Schmidt, Martin Dreyling
Jan 13, 2009·PloS One·Jonathan H LinPeter Walter
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Qiuyan WangYihong Ye
Apr 25, 2009·Seminars in Hematology·Constantine S MitsiadesPaul G Richardson
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ashraf BadrosSteven Grant
Oct 16, 2009·The New England Journal of Medicine·Richard S HotchkissPaul E Swanson

❮ Previous
Next ❯

Citations

Sep 27, 2012·Apoptosis : an International Journal on Programmed Cell Death·Muktheshwar GandesiriRegine Schneider-Stock
Dec 17, 2010·Investigational New Drugs·Michael DickinsonH Miles Prince
Apr 2, 2011·The Journal of Biological Chemistry·Alyson J SmithScott H Kaufmann
May 24, 2013·Anti-cancer Drugs·Yong-Zhan ZhenYong-Su Zhen
Apr 29, 2014·Pharmacology & Therapeutics·Prithviraj BoseSteven Grant
Jun 13, 2012·Best Practice & Research. Clinical Haematology·Beata Holkova, Steven Grant
Sep 30, 2014·Expert Opinion on Pharmacotherapy·Prithviraj BoseSteven Grant
Apr 11, 2017·Cancer Chemotherapy and Pharmacology·Qiang WangHui Ding
Sep 9, 2017·Journal of Experimental & Clinical Cancer Research : CR·Xuanxuan DaiGuang Liang
Jun 16, 2018·Cancers·Christine M CaltonSteffan T Nawrocki
Jun 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sílvia Xargay-TorrentDolors Colomer
Aug 31, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Warren FiskusKapil Bhalla
Mar 29, 2013·Molecular Cancer Therapeutics·Holly A F StessmanBrian G Van Ness
Jun 28, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer E AmengualOwen A O'Connor
Apr 4, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dhrubajyoti NagSubhrajit Saha
Mar 15, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rekha RaoKapil N Bhalla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.